Android Compatible System Cleared by FDA and App Available in the Google Play Store, Device available on Amazon.
Glooko, Inc., makers of an innovative mobile solution for diabetes management, today announced it has launched an Android-compatible version of its next generation Glooko Diabetes Management System. The Glooko system for Android, consisting of the mobile app, MeterSync Cable and web dashboards, is the only FDA-cleared mobile diabetes management system that supports the transfer of blood glucose data direct from dozens of compatible glucose meters into many Android devices.
Glooko’s Android app will integrate into the existing Glooko Diabetes Management web dashboards, which enable healthcare professionals to identify at-risk patients, analyze blood glucose levels for patterns and make informed therapeutic decisions. The new product has been cleared by the FDA’s 510(k) process.
“Our diabetes management system aims for universal access for people with diabetes across the globe,” said Rick Altinger, Glooko CEO. “By leveraging Android’s market reach, we hope that providers, health systems and payers can efficiently manage their diabetes patients, improve outcomes and lower costs.” In support of Glooko’s market expansion into health systems, the company recently joined the Samsung Enterprise Alliance Program (SEAP) to leverage Samsung’s extensive global sales and marketing network.
By adding support for the Android mobile operating system, Glooko now provides a diabetes management platform that is accessible to tens of millions of people with diabetes. According to a recent report by comScore on key trends in the smartphone industry, Android is ranked as the number one smartphone platform with 52% market share in the US and 65% in Europe. With the addition of Android support, Glooko enables people with diabetes to easily collect, view and share their blood glucose readings on many Android phones including Samsung, HTC and LG models. For professionals and disease management staffs, the Glooko diabetes management system offers the analytical tools that can enable consistent care across their diabetes patients along with an improved ability to advise their patients remotely. By using Glooko, health systems aim to create a higher level of adherence to treatment plans among their diabetes population.
The Glooko Diabetes Management System for Android runs on devices using the Android operating system, including phones such as the industry leading Samsung Galaxy SIII and S4. Using Glooko’s mobile application, these devices can currently download glucose data from dozens of compatible meters, including but not limited to Roche’s ACCU-CHEK® Aviva (Black), Abbott’s FreeStyle Lite®, and Lifescan’s OneTouch® Ultra®2, OneTouch® UltraLink®, and a variety of Nipro meters. Glooko expects to add even more devices soon, including additional glucose meters and eventually insulin pumps.
To learn more about Glooko, including a full list of compatible devices, visit http://www.glooko.com
Glooko™ is an innovative Silicon Valley startup with a unique solution for people with diabetes. Glooko’s products – the Glooko mobile app and MeterSync Cable for iOS and Android– enable people with diabetes to easily collect, view and share the information needed to help them successfully control their blood glucose readings. It has been hailed by users and industry influencers for its ease of use and ability to deliver context to daily data collected by people with diabetes on both a mobile and web-based platform. The company was founded in 2010 by technologist Yogen Dalal and mobile and web app developer, Sundeep Madra. Endocrinologist Michael S. Greenfield, M.D., is chief medical officer. The company’s first generation product received FDA 510(k) clearance in December 2012. Many on the Glooko team, including the founders, have a personal connection to diabetes. Glooko is backed by several Silicon Valley innovators including former Facebook, Apple and Cisco executives. Together they are committed to helping people with diabetes live their lives, while effortlessly managing their diabetes.